Diet & Clinical Outcomes in Multiple Sclerosis MStranslate November 13, 2024 Diet, Lifestyle, Research Research Summary: A pro-inflammatory diet in people with multiple sclerosis is associated with an increased rate of relapse and increased FLAIR...
Study Provides New Insights Into Disease Progression MStranslate November 6, 2024 Research Research Summary: Senolytic treatment diminishes microglia and decreases severity of experimental autoimmune encephalomyelitis While we now have a...
Bile Acids: A Novel Multiple Sclerosis Therapy? MStranslate August 6, 2024 Research, Treatments Research Summary: Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease Researchers are...
Long-term HSCT Outcomes in Norway MStranslate July 9, 2024 Research, Stem Cells, Treatments Research Summary: Autologous hematopoietic stem cell transplantation for multiple sclerosis: Long-term follow-up data from Norway Although not a...
‘Wearing Off’ Of MS Treatments Between Doses MStranslate July 1, 2024 Research, Treatments Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major...
Retinoic Acid and Calcitriol May Promote Remyelination MStranslate June 25, 2024 Remyelination, Research, Treatments Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell...
Is Vitamin B12 Important in Multiple Sclerosis? MStranslate December 20, 2023 Fingolimod, Research, Vitamin B12 2 Comments Research Summary: FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis The...
BTK Inhibitors in the Treatment of MS MStranslate December 12, 2023 Clinical Trials, Research, Treatments What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B...
MS Milan 2023: Daily Research Summary Videos MStranslate October 19, 2023 ACTRIMS, ECTRIMS, Research 1 Comment MS Milan 2023 was the 9th Joint ECTRIMS-ACTRIMS Meeting, coordinated by the European Congress for the Treatment and Research Into Multiple Sclerosis...
Clemastine Repairs Damage In Multiple Sclerosis MStranslate July 4, 2023 Clinical Trials, Neuroimaging, Remyelination Research Summary: MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial Remyelination or myelin repair is...
